The cancer gene therapy market's growth is propelled by rising R&D investments, increasing cancer incidence, and supportive regulations. Key opportunities lie in advancements in immunotherapy and ...

A team led by scientists at Harvard Medical School, Massachusetts General Hospital, and the Broad Institute of MIT and ...

Researchers have developed a new lipid for delivering mRNA that is safer and more effective than current technologies. By ...

A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate ...

Researchers at the University of Oslo and Oslo University Hospital have developed a promising new immunotherapy targeting the ...

A study led by Vincenzo Condello and Christofer Juhlin of the Karolinska Institutet explores why some papillary thyroid ...

Genetic testing can identify patients with HPV-positive throat cancer who may benefit from lower radiation doses, according ...

Cancer scientists have been working against the clock for decades to outsmart a disease that comes back more powerfully after ...

Stanford researchers and their collaborators have revealed a new device that could change the way scientists conduct ...

In a conversation with THE WEEK, Dr Kshitija Patil highlights the challenges in diagnosis, prevention, and therapy, ...

With operations going at the 12,000-square-foot site, the company with headquarters in Switzerland now boasts three locations dedicated to producing its bladder cancer treatment Adstiladrin. The ...